Merck, Pfizer join Accenture's R&D cloud; Almac expands in the U.K.;

> Accenture ($ACN) has recruited Merck ($MRK) and Pfizer ($PFE) to join in on its R&D analytics platform. Item

> CRO Access BIO has signed on to help BioRestorative Therapies prepare its lead candidate for the FDA IND process. Story

> Contract manufacturer Almac has expanded its packaging operations in the U.K. News

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.